Myopathy as a cause of fatigue in long-term post-COVID-19 symptoms: Evidence of skeletal muscle histopathology코로나19 이후 장기 증상에서 피로의 원인인 근병증: 골격근 조직병리학의 증거Article Published on 2022-09-012022-09-11 Journal: European journal of neurology [Category] COVID19(2023년), SARS, 변종, [키워드] ABC acute disease acute infection affected age analyzed Antigen basal lamina biopsy Capillaries capillary cells changes changes in COVID-19 symptoms Cytochrome C cytochrome c oxidase diagnosed disease electromyography electron microscopy evidence of expression fatigue fiber histological change histological changes histopathological Histopathology human leukocyte antigen indication indications Inflammation Injury less leukocyte long-term COVID Microscopy Mild mitochondrial Most patients muscle muscle biopsy muscle fiber muscle weakness muscular myalgia myopathic Myopathy Patient patients post-COVID syndrome Quantitative reduced reported SARS-CoV-2 Skeletal muscle skeletal muscles Symptoms syndrome T lymphocyte T lymphocytes two patients variant variety weakness [DOI] 10.1111/ene.15435 PMC 바로가기 [Article Type] Article
Clinical characteristics of the Omicron variant – results from a Nationwide Symptoms Survey in the Faroe IslandsArticle Published on 2022-09-012022-11-16 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 변종, [키워드] acute phase appear asked Asymptomatic Characteristics chill clinical Clinical characteristics, Faroe Islands conducted confidence interval Control control group controls COVID COVID-19 cross-sectional dominant fatigue Fever illness individual Infection infections island less Mild moderate MOST omicron Patient Positive test question questionnaire reported risk SARS-CoV-2 severe disease severity survey Symptom Symptoms variant variants [DOI] 10.1016/j.ijid.2022.07.005 PMC 바로가기
Effectiveness of the third dose of BNT162b2 vaccine on neutralizing Omicron variant in the Japanese population일본 인구에서 오미크론 변이체 중화에 대한 BNT162b2 백신 3차 접종의 효과Article Published on 2022-09-012022-09-11 Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] acquired immunity Anti-receptor binding domain antibody anti-SARS-CoV-2 antibody binding domain BNT162b2 BNT162b2 vaccine booster booster vaccination collected contribute COVID-19 case COVID-19 cases declines Delta dose Efficacy elevated evaluated event fatigue Fever healthcare worker Healthcare workers humoral Humoral immunity Immunity individual Japanese Local local swelling median myalgia neutralization Neutralizing Neutralizing activity neutralizing antibody of BNT162b2 omicron Omicron variant Pfizer promotion provide Pseudotyped viruses Questionnaires reduced SARS-CoV-2 second dose sera serum sample serum samples Side effect Side effects significantly swelling Toyama U/mL university vaccination Vaccine variant variants was measured Waves wild-type [DOI] 10.1016/j.jiac.2022.05.009 PMC 바로가기 [Article Type] Article
A third dose of the BNT162b2 mRNA vaccine significantly improves immune responses among liver transplant recipientsBNT162b2 mRNA 백신의 세 번째 접종은 간 이식 환자의 면역 반응을 크게 향상시킵니다Article Published on 2022-09-012022-09-12 Journal: Journal of hepatology [Category] Fulltext, MERS, 진단, [키워드] Adverse adverse effect adverse effects age Anti-RBD IgG anti-SARS-CoV-2 antibody Antibody Response binding domain BNT162b2 BNT162b2 mRNA BNT162b2 mRNA vaccine Booster vaccine cellular immune responses cellular response center correlated determine dose doses Effect evaluate evaluated Factor fatigue Follow-up geometric humoral humoral immune response IgG immune immune response Immunity Immunosuppression immunosuppressive medications IMPROVE inhibitor liver liver transplant recipients local pain majority male median age Mild monotherapy neutralizing antibody Older age Patient predict RBD recipient recipients reported response Side effect side effects BNT162b2 mRNA vaccine significantly solid organ transplant T-cell the patient third dose Treatment Vaccine vaccine dose [DOI] 10.1016/j.jhep.2022.03.042 PMC 바로가기 [Article Type] Article
COVID-19 vaccination in people with multiple sclerosis, real-life experienceResearch article Published on 2022-09-012022-10-05 Journal: Clinical neurology and neurosurgery [Category] COVID19(2023년), SARS, 임상, [키워드] acute respiratory syndrome Adverse adverse events age approved association BNT162b2 BNT162b2 vaccine ChAdOx1 nCoV-19 Clinical data Cohort common adverse event Complete Complication coronavirus Coronavirus disease 2019 COVID-19 COVID-19 infection COVID-19 vaccination COVID-19 vaccine demographic disease dose event fatigue females Fever first dose General population increased risk Infection injection investigated Kuwait mRNA multiple sclerosis National objective Occurrence Pain Patient Pfizer-BioNTech questionnaire reduce Registered reported resolved Result risk Safe SARS-CoV-2 subjects Symptom Symptoms the vaccine Therapies therapy treated vaccination Vaccine virus were recorded WhatsApp worsening [DOI] 10.1016/j.clineuro.2022.107374 [Article Type] Research article
Two-Year Health Outcomes in Hospitalized COVID-19 Survivors in ChinaArticle Published on 2022-09-012022-11-16 Journal: JAMA Network Open [Category] SARS, 변종, [키워드] 95% CI acute illness Admission age Analysis Anxiety change Chest China chronic obstructive cohort study conducted COVID-19 decrease defined discharge Dyspnea Factor fatigue Follow-up follow-up study follow-up visits Health higher risk hospital hospital discharge Hospitalization hospitalized COVID-19 identify incidence increased risk Infection intensive care IQR longitudinal cohort study male median MOST myalgia Odds ratio omicron outcome Patient patients who survived patients with COVID-19 persistence pulmonary disease questionnaire required resolved severe disease Severity of disease survivor Survivors Symptom symptom burden Symptoms total score variant virus World Health Organization worsening Wuhan, China [DOI] 10.1001/jamanetworkopen.2022.31790 PMC 바로가기
ORAL NEUROPATHIC PAIN POST-COVID-19 IN A YOUNG BRAZILIAN PATIENTConference abstract Published on 2022-09-012022-10-05 Journal: Oral surgery, oral medicine, oral pathology and or [Category] 변종, [키워드] Anosmia complication of COVID-19 complications Concentration concerning cough COVID-19 cytidine develop disease fatigue information knowledge Medicine memory myalgia nasal congestion neurologic neuropathic neuropathic pain oral oral examination osseous Pain patients with COVID-19 positive presenting reported service sore throat Treatment uridine vitamin B12 worsening [DOI] 10.1016/j.oooo.2022.01.079 [Article Type] Conference abstract
Tetrandrine Treatment May Improve Clinical Outcome in Patients with COVID-19Article Published on 2022-09-012022-11-15 Journal: Medicina [Category] SARS, 치료제, [키워드] antibiotic Antibiotics association China Chinese clinical Clinical outcome collected cough COVID-19 COVID-19 pandemic COVID-19 patient defined diagnosis of COVID-19 effective Effectiveness Factor fatigue group IMPROVE indicated material Medicine Mild moderate natural antiviral patients SARS-CoV-2 significant difference tetrandrine Traditional Chinese medicine treat treating COVID-19 Treatment treatment for COVID-19 were assessed with COVID-19 [DOI] 10.3390/medicina58091194 PMC 바로가기
Impact of the loss of smell on the sleep quality and fatigue level in COVID‑19 survivorsArticle Published on 2022-09-012023-07-08 Journal: European archives of oto-rhino-laryngology : offic [Category] COVID19(2023년), [키워드] coronavirus COVID-19 Depression fatigue Loss of Smell Sleep [DOI] 10.1007/s00405-022-07381-z PMC 바로가기
Severe refractory warm autoimmune haemolytic anaemia after the SARS-CoV-2 Pfizer-BioNTech vaccine (BNT162b2 mRNA) managed with emergency splenectomy and complement inhibition with eculizumabArticle Published on 2022-08-312022-11-15 Journal: BMJ case reports [Category] SARS, 진단, [키워드] 48 hour Autoimmune Bilirubin Blood BNT162b2 mRNA Chest complement Complement pathway Corticosteroid described disease eculizumab fatigue first dose haematology (incl blood transfusion) Haemoglobin highlight inhibitor initiated investigation jaundice lactate dehydrogenase life-threatening liver male over Pfizer-BioNTech SARS-CoV-2 standard treatment the patient the SARS-CoV-2 transplantation Urine Vaccine warm was performed [DOI] 10.1136/bcr-2022-250774 PMC 바로가기